Staels W, De Schepper J, Becker M, Lysy P, Klink D, Logghe K
Front Endocrinol (Lausanne). 2024; 15:1459998.
PMID: 39415786
PMC: 11482521.
DOI: 10.3389/fendo.2024.1459998.
Doknic M, Stojanovic M, Markovic A
Int J Mol Sci. 2024; 25(19).
PMID: 39408643
PMC: 11476696.
DOI: 10.3390/ijms251910313.
Fava D, Guglielmi D, Pepino C, Angelelli A, Casalini E, Varotto C
J Clin Endocrinol Metab. 2024; 110(1):78-90.
PMID: 38913686
PMC: 11651695.
DOI: 10.1210/clinem/dgae408.
Smyczynska J, Hilczer M, Smyczynska U, Lewinski A, Stawerska R
Int J Mol Sci. 2024; 25(11).
PMID: 38891927
PMC: 11171613.
DOI: 10.3390/ijms25115739.
Singh P, Seth A
Indian J Pediatr. 2023; 90(11):1134-1141.
PMID: 37542570
DOI: 10.1007/s12098-023-04780-w.
Perceptions of Youth and Parent Decision-Making Roles Regarding Recombinant Human Growth Hormone Treatment.
Fremont E, Friedrich E, Feudtner C, Grimberg A, Miller V
Endocrines. 2023; 3(4):590-600.
PMID: 37152718
PMC: 10162591.
DOI: 10.3390/endocrines3040050.
Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis.
Yuen K, Johannsson G, Ho K, Miller B, Bergada I, Rogol A
Endocr Connect. 2023; 12(7).
PMID: 37052176
PMC: 10305501.
DOI: 10.1530/EC-22-0504.
Diagnosis of childhood and adolescent growth hormone deficiency using transcriptomic data.
Garner T, Wangsaputra I, Whatmore A, Clayton P, Stevens A, Murray P
Front Endocrinol (Lausanne). 2023; 14:1026187.
PMID: 36864831
PMC: 9973753.
DOI: 10.3389/fendo.2023.1026187.
Insulin-like growth factor-1 levels are associated with high comorbidity of metabolic disorders in obese subjects; a Japanese single-center, retrospective-study.
Kubo H, Sawada S, Satoh M, Asai Y, Kodama S, Sato T
Sci Rep. 2022; 12(1):20130.
PMID: 36418379
PMC: 9684525.
DOI: 10.1038/s41598-022-23521-1.
Applying precision medicine to the diagnosis and management of endocrine disorders.
Bidlingmaier M, Gleeson H, Latronico A, Savage M
Endocr Connect. 2022; 11(10).
PMID: 35968864
PMC: 9513637.
DOI: 10.1530/EC-22-0177.
Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
Johannsson G, Touraine P, Feldt-Rasmussen U, Pico A, Vila G, Mattsson A
J Clin Endocrinol Metab. 2022; 107(7):1906-1919.
PMID: 35368070
PMC: 9202689.
DOI: 10.1210/clinem/dgac199.
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
Boguszewski M, Boguszewski C, Chemaitilly W, Cohen L, Gebauer J, Higham C
Eur J Endocrinol. 2022; 186(6):P35-P52.
PMID: 35319491
PMC: 9066587.
DOI: 10.1530/EJE-21-1186.
Approach to the Patient: Management of Pituitary Hormone Replacement Through Transition.
Cerbone M, Katugampola H, Simpson H, Dattani M
J Clin Endocrinol Metab. 2022; 107(7):2077-2091.
PMID: 35262704
PMC: 9202712.
DOI: 10.1210/clinem/dgac129.
Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?.
Smyczynska J, Hilczer M, Lewinski A, Smyczynska U, Stawerska R
Pediatr Endocrinol Diabetes Metab. 2022; 27(4):258-265.
PMID: 35114767
PMC: 10226357.
DOI: 10.5114/pedm.2021.112694.
Contribution of Ghrelin to the Pathogenesis of Growth Hormone Deficiency.
Lewinski A, Karbownik-Lewinska M, Wieczorek-Szukala K, Stasiak M, Stawerska R
Int J Mol Sci. 2021; 22(16).
PMID: 34445772
PMC: 8396656.
DOI: 10.3390/ijms22169066.
Mapping the journey of transition: a single-center study of 170 childhood-onset GH deficiency patients.
Doknic M, Stojanovic M, Soldatovic I, Milenkovic T, Zdravkovic V, Jesic M
Endocr Connect. 2021; 10(8):935-946.
PMID: 34259648
PMC: 8428021.
DOI: 10.1530/EC-21-0274.
An Adapted Model for Transition to Adult Care in Young Adults with Prader-Willi Syndrome.
Pedersen M, Hoybye C
J Clin Med. 2021; 10(9).
PMID: 34066432
PMC: 8124992.
DOI: 10.3390/jcm10091991.
Development of a predictive model of growth hormone deficiency and idiopathic short stature in children.
Cong M, Qiu S, Li R, Sun H, Cong L, Hou Z
Exp Ther Med. 2021; 21(5):494.
PMID: 33791003
PMC: 8005695.
DOI: 10.3892/etm.2021.9925.
Growth hormone deficiency and the transition from pediatric to adult care.
Tavares A, Collett-Solberg P
J Pediatr (Rio J). 2021; 97(6):595-602.
PMID: 33773961
PMC: 9432185.
DOI: 10.1016/j.jped.2021.02.007.
Clinical, Diagnostic, and Therapeutic Aspects of Growth Hormone Deficiency During the Transition Period: Review of the Literature.
Spaziani M, Tarantino C, Tahani N, Gianfrilli D, Sbardella E, Isidori A
Front Endocrinol (Lausanne). 2021; 12:634288.
PMID: 33716984
PMC: 7943868.
DOI: 10.3389/fendo.2021.634288.